XML 55 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of non-cash stock-based compensation expense by department
A summary of non-cash stock-based compensation expense by expense category included in the Company's consolidated statements of operations for the years ended December 31, 2023, 2022, and 2021 is as follows:
Year Ended December 31,
(In thousands)
202320222021
Cost of sales
$20,761 $19,218 $16,835 
Research and development
41,242 33,825 49,723 
Sales and marketing
65,552 62,568 55,716 
General and administrative
103,757 91,212 216,952 
Total stock-based compensation$231,312 $206,823 $339,226 
Schedule of valuation assumptions
The fair value of ESPP shares is based on the assumptions in the following table:
Year Ended December 31,
202320222021
Risk-free interest rates
4.68% - 4.71%
1.49% - 4.71%
0.04% - 0.16%
Expected term (in years)
1.25
0.5 - 2
0.5 - 2
Expected volatility
63.13% - 67.30%
50.94% - 63.13%
43.00% - 68.51%
Dividend yield0%0%0%
Summary of stock option activity under the Stock Plans
A summary of stock option activity under the Stock Plans is as follows:
OptionsShares
Weighted Average Exercise Price
Weighted Average Remaining Contractual Term (Years)
Aggregate Intrinsic Value (1)
(Aggregate intrinsic value in thousands)
Outstanding, January 1, 2023
1,517,876 $44.82 4.7
Exercised(194,629)16.44 
Forfeited(37,074)95.02 
Outstanding, December 31, 2023
1,286,173 $47.67 3.8$42,878 
Vested and expected to vest, December 31, 2023
1,286,173 $47.67 3.8$42,878 
Exercisable, December 31, 2023
1,228,594 $45.32 3.7$42,878 
_________________________________
(1)     The total intrinsic value of options exercised during the years ended December 31, 2023, 2022, and 2021 was $11.7 million, $36.4 million, and $155.8 million, respectively, determined as of the date of exercise.
Summary of restricted stock and restricted stock unit activity under the Stock Plans
A summary of restricted stock and restricted stock unit activity is as follows:
Restricted SharesWeighted Average Grant Date Fair Value (1)
Outstanding, January 1, 2023
5,254,709 $85.87 
Granted3,510,373 62.36 
Released (2)(1,797,915)88.28 
Forfeited(694,404)73.54 
Outstanding, December 31, 2023
6,272,763 $73.39 
_________________________________
(1)     The weighted average grant date fair value of the restricted stock units granted during the years ended December 31, 2022 and 2021 was $68.18 and $129.16, respectively.
(2)     The fair value of restricted stock units vested and converted to shares of the Company's common stock was $158.2 million, $117.6 million, and $219.4 million for the years ended December 31, 2023, 2022, and 2021, respectively.
Share-based Payment Arrangement, Performance Shares, Activity
A summary of performance share unit activity is as follows:
Performance Share Units (1)Weighted Average Grant Date Fair Value (2)
Outstanding, January 1, 2023967,846 $102.58 
Granted782,966 80.50 
Released (3)(12,284)78.32 
Forfeited(140,727)93.73 
Outstanding, December 31, 20231,597,801 $92.73 
_________________________________
(1)     The performance share units listed above assumes attainment of maximum payout rates as set forth in the performance criteria. Applying actual or expected payout rates, the number of outstanding performance share units as of December 31, 2023 was 772,906.
(2)     The weighted average grant date fair value of the performance share units granted during the years ended December 31, 2022 and 2021 was $89.43 and $138.09, respectively.
(3)     The fair value of performance share units vested and converted to shares of the Company's common stock was $1.0 million and $27.2 million for the years ended December 31, 2023 and 2022, respectively. There were no performance share units vested and converted to shares of the Company's common stock during the year ended December 31, 2021.
Schedule of shares of common stock issued
A summary of ESPP activity is as follows:
Year Ended December 31,
(in thousands, except share and per share amounts)202320222021
Shares issued under the 2010 Purchase Plan924,448 668,605331,769
Cash received under the 2010 Purchase Plan$28,344 $25,491 $23,070 
Weighted average fair value per share of stock purchase rights granted during the period$16.32 $17.52 $34.93 
Schedule of Common Stock Issued
The 924,448 shares issued during the year ended December 31, 2023 were as follows:
Offering period ended
Number of Shares
Weighted Average price per Share
April 30, 2023544,453 $30.02 
October 31, 2023379,995 $31.57 
Summary of shares of authorized common stock reserved for issuance
The Company has reserved shares of its authorized common stock for issuance pursuant to its employee stock purchase and equity plans, including all outstanding stock option grants noted above at December 31, 2023, as follows:
Shares reserved for issuance
2019 Stock Plan16,046,161 
2010 Purchase Plan
1,834,193 
17,880,354